The latest news from dabl >
June 2015: dabl attending 25th Scientific Meeting of the ESH, June 12th-15th 2015, Milan, Italy.
dabl is pleased to announce that its representatives will be in attendance at the ESH, June 12th-15th, Milan.
If you would like to arrange to meet with a dabl representative, please contact us at firstname.lastname@example.org or call on +353 (0) 1 278 0247.
December 2014: dabl announces major update to its 24-hour ABPM reporting and diagnostic system
dabl is pleased to announce that in keeping with its ongoing review and development of its systems it has released its latest version for its 24-hour ABPM diagnostic and reporting system. The upgrade includes a number of enhancements for patient assessment, the addition of three new devices which can be linked to the system and an increase in the number of performance improvements.
Oct 2012: dabl and Quintiles announce a strategic alliance.
dabl and Quintiles (the world's leading provider of biopharmaceutical services), announce a strategic alliance. Through the alliance, Quintiles' customers worldwide will have access to dabl's online blood pressure monitoring solutions to enhance the safety and efficacy of global clinical trials.
Aug 2011: NICE radically overhauls hypertension guidelines to include ABPM
New guidelines now recommend the use of 24-hr ABPM to diagnose hypertension.
Apr 2011: dabl shortlisted for another award
dabl has been shortlisted as a finalist of the 2011 Biomnis Healthcare Innovation Award.
Feb 2011: Draft NICE Guidelines recommend use of 24-hr ABPM
GPs in the UK are set for a huge change in the management of millions of patients with high blood pressure, after draft NICE guidelines recommended use of 24-hour ABPM to make all new diagnoses and guide treatment.
Jan 2011: dabl Ltd to exhibit at the 23rd DIA Annual Euromeeting in Geneva
dabl Ltd is pleased to announce that we will exhibit at the upcoming 23rd DIA Annual EuroMeeting (28-30 March 2010 in Geneva, Switzerland). Visit us at booth no. 1186
Jan 2011: Dedicated dabl Research website launched
dabl has launched a new dedicated website for clinical trials www.dablresearch.com.
dabl provides centralised Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) systems to assess the efficacy of investigational anti-hypertensive drugs and to monitor the cardiac safety of non-cardiovascular drugs.
About dabl Ltd
dabl Ltd is a leading developer and provider of expert healthcare management software systems and research tools for the prevention and management of stroke, heart attack, blood pressure and a range of other cardiovascular conditions.